Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 5;12(10):1514.
doi: 10.3390/antibiotics12101514.

Antibacterial and Anti-Efflux Activities of Cinnamon Essential Oil against Pan and Extensive Drug-Resistant Pseudomonas aeruginosa Isolated from Human and Animal Sources

Affiliations

Antibacterial and Anti-Efflux Activities of Cinnamon Essential Oil against Pan and Extensive Drug-Resistant Pseudomonas aeruginosa Isolated from Human and Animal Sources

Mohamed A I Abdelatti et al. Antibiotics (Basel). .

Abstract

Pseudomonas aeruginosa is notorious for its ability to develop a high level of resistance to antimicrobial agents. Resistance-nodulation-division (RND) efflux pumps could mediate drug resistance in P. aeruginosa. The present study aimed to evaluate the antibacterial and anti-efflux activities of cinnamon essential oil either alone or combined with ciprofloxacin against drug resistant P. aeruginosa originated from human and animal sources. The results revealed that 73.91% of the examined samples were positive for P. aeruginosa; among them, 77.78% were of human source and 72.73% were recovered from animal samples. According to the antimicrobial resistance profile, 48.73% of the isolates were multidrug-resistant (MDR), 9.2% were extensive drug-resistant (XDR), and 0.84% were pan drug-resistant (PDR). The antimicrobial potential of cinnamon oil against eleven XDR and one PDR P. aeruginosa isolates was assessed by the agar well diffusion assay and broth microdilution technique. The results showed strong antibacterial activity of cinnamon oil against all tested P. aeruginosa isolates with inhibition zones' diameters ranging from 34 to 50 mm. Moreover, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of cinnamon oil against P. aeruginosa isolates ranged from 0.0562-0.225 µg/mL and 0.1125-0.225 µg/mL, respectively. The cinnamon oil was further used to evaluate its anti-efflux activity against drug-resistant P. aeruginosa by phenotypic and genotypic assays. The cartwheel test revealed diminished efflux pump activity post cinnamon oil exposure by two-fold indicating its reasonable impact. Moreover, the real-time quantitative polymerase chain reaction (RT-qPCR) results demonstrated a significant (p < 0.05) decrease in the expression levels of MexA and MexB genes of P. aeruginosa isolates treated with cinnamon oil when compared to the non-treated ones (fold changes values ranged from 0.4204-0.7474 for MexA and 0.2793-0.4118 for MexB). In conclusion, we suggested the therapeutic use of cinnamon oil as a promising antibacterial and anti-efflux agent against drug-resistant P. aeruginosa.

Keywords: MexB and MexA genes; Pseudomonas aeruginosa; antimicrobial activity; cinnamon oil; efflux pumps.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of checkerboard result vs. both of ciprofloxacin (A) and cinnamon oil (B), efflux pump activity vs. anti-Efflux pump activity for both of MC EtBr (C) and index (D). CIP, ciprofloxacin, MC EtBr, minimum EtBr concentration. * Statistically significant at p-value < 0.05, *** highly significant at p-value < 0.001.
Figure 2
Figure 2
Relative expression of the efflux pump genes post treatment with cinnamon essential oil in drug resistant P. aeruginosa isolates. As presented in Table 4, chicken cloacal swab code no.9, human burn code no. 11 and mastitis milk code no. 12.

References

    1. Klockgether J., Cramer N., Wiehlmann L., Davenport C.F., Tümmler B. Pseudomonas aeruginosa genomic structure and diversity. Front. Microbiol. 2011;2:150. doi: 10.3389/fmicb.2011.00150. - DOI - PMC - PubMed
    1. Qin S., Xiao W., Zhou C., Pu Q., Deng X., Lan L., Liang H., Song X., Wu M. Pseudomonas aeruginosa: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target. Ther. 2022;7:1–27. doi: 10.1038/s41392-022-01056-1. - DOI - PMC - PubMed
    1. Tartor Y., El-Naenaeey E. RT-PCR detection of exotoxin genes expression in multidrug resistant Pseudomonas aeruginosa. Cell. Mol. Biol. 2016;62:56–62. - PubMed
    1. Arzanlou M., Chai W.C., Venter H. Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria. Essays Biochem. 2017;61:49–59. - PubMed
    1. Moradali M.F., Ghods S., Rehm B.H. Pseudomonas aeruginosa lifestyle: A paradigm for adaptation, survival, and persistence. Front. Cell. Infect. Microbiol. 2017;7:39. doi: 10.3389/fcimb.2017.00039. - DOI - PMC - PubMed

LinkOut - more resources